DBV Technologies (France)
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for DBV Technologies (France), France, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
218
Total Open
Publications
111
Total
Citations
3.9K
Open Access
Percentage
51%
Total
Publications
218
Total Open
Publications
111
Total
Citations
3.9K
Breakdown
Publisher Open
27%
Both
17%
Other Platform Open
5%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 16%
15
Hybrid 29%
26
No Guarantees 55%
50
Other Platform Open
Institution 57%
29
Domain 55%
28
Other Internet 14%
7
Public 2%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 28 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 11 |
DOI | Other Internet | 6 |
Technical University of Munich | Institution | 5 |
Imperial College London | Institution | 3 |
Harris County Public Library | Institution | 3 |
University College Cork - Cork Open Research Archive | Institution | 2 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
Europe PMC | Domain | 2 |
Zenodo | Public | 1 |